Company / Net Income
ANAPTYSBIO, INC Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$13.2M
FY2025
5-year range
-$163.6M / -$13.2M
FY2021-FY2025
Trend
+90.9%
vs FY2024
Sector context
#67 of 216
Health Care
What the data says
At -$13M, ANAPTYSBIO, INC's net income ranks #67 of 216 in the Health Care sector. Net Income has fluctuated over the past 10 years, ranging from -$164M in FY2023 to -$4M in FY2016.
Based on SEC 10-K filings.
-$13M in FY2025.
Improved from -$164M to -$13M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#67 of 216 in Health CareTop 31% of 216This company -$13.2M Sector average $454.3M
▼
-102.9% below sector average
Key checks
Key Insights
- In FY2025, net income increased 90.9% year-over-year.
- Ranks #67 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2016.
- Lowest net income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$13.2M | +90.9% |
| FY2024 | -$145.2M | +11.2% |
| FY2023 | -$163.6M | -720.9% |
| FY2022 | -$19.9M | +79.5% |
| FY2021 | -$97.3M | -57.9% |
| FY2020 | -$61.7M | -105.0% |
| FY2019 | -$30.1M | +51.2% |
| FY2018 | -$61.7M | -1040.7% |
| FY2017 | -$5.4M | -26.9% |
| FY2016 | -$4.3M | +21.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026